Category
New / Revised 2026
Focus / Keywords
REST trial found harm signal for routine use; targeted selective use per 2022 consensus may differ
Recent Evidence 2025-26
System
Respiratory
REST trial found harm signal for routine use; targeted selective use per 2022 consensus may differ